A U.S. study of over 500 youth aged 14–24 found high awareness but widespread hesitation about using semaglutide for weight ...

The global Oral Proteins & Peptides Market , valued at US$7.35 billion in 2024, is forecasted to grow at a robust CAGR of ...

An estimated 24,499 people visited the ED for adverse events related to semaglutide in the 2 years after its approval for ...

GLP-1 medications have been going viral for their transformative effects, but now people are raising concerns about a ...

Compared with DPP4 inhibitors, SGLT2 inhibitors reduce the risk for kidney and ureteral stones in patients with type 2 diabetes, including those with a stone history. Sodium-glucose cotransporter 2 ...